In Vitro Differentiation of Human Cord Blood-derived Unrestricted Somatic Stem Cells Towards an Endodermal Pathway
Overview
Pharmacology
Affiliations
Background: Pluripotent unrestricted somatic stem cells (USSC) from UC blood can differentiate into hepatic cells in the in utero sheep model, resulting in 20% human albumin-producing parenchymal hepatic cells without cell fusion or tumor-formation events. Additionally, we have shown in vitro differentiation of USSC by hepatocyte growth factor and oncostatin M induction, causing changes in the gene expression towards the endodermal lineage. Positive glycogen synthase expression and a positive periodic acid-schiff reaction demonstrated a functional production of polysaccharides in the cells.
Methods: We describe the in vitro differentiation of USSC towards an endodermal pathway using different matrices, growth factors and organic substances. Also, co-cultures of USSC with primary cells of endodermal tissue were prepared to mimic the biologic niche. We investigated the effect of direct co-culture of USSC with primary rat hepatocytes or with sheep tissue of endodermal origin. Direct co-cultures were set up to ensure cell-cell contacts. For co-cultures without cell-cell contacts, transwell inlays with 1-microm membranes were used to separate the cells. Furthermore, the effect of endodermally conditioned medium was investigated. Changes in the gene expression patterns were analyzed by RT-PCR.
Results: We have shown that USSC can differentiate in vitro into an endodermal-like cell with a phenotype similar to hepatic cells. Differentiation of USSC with growth factors, retinoic acid, matrigel matrix and different co-cultures led to an increased expression of albumin and also to the detection of GSC, SOX 17, Cyp2B6, Cyp3A4, Gys2, HNF4a, ISL-1 and Nkx6.1. In addition, functional albumin secretion was observed.
Discussion: Although the differentiation assays demonstrated here produce only an immature hepatocyte-like cell, endodermaly differentiated USSC might be a useful alternative for cell replacement in the future.
Herten M, Zilkens C, Thorey F, Tassemeier T, Lensing-Hohn S, Fischer J Molecules. 2019; 24(2).
PMID: 30650584 PMC: 6358876. DOI: 10.3390/molecules24020295.
Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine.
Sultana T, Lee S, Yoon H, Lee J Stem Cells Int. 2018; 2018:8329174.
PMID: 30123294 PMC: 6079340. DOI: 10.1155/2018/8329174.
Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood.
Sotnezova E, Andreeva E, Grigoriev A, Buravkova L Acta Naturae. 2016; 8(3):6-16.
PMID: 27795840 PMC: 5081707.
Langroudi L, Jamshidi-Adegani F, Shafiee A, Ali Hosseini Rad S, Keramati F, Azadmanesh K Tumour Biol. 2015; 36(10):7765-74.
PMID: 25941115 DOI: 10.1007/s13277-015-3519-7.
Soleimani M, Khorsandi L, Atashi A, Nejaddehbashi F Cell J. 2014; 16(1):43-52.
PMID: 24518974 PMC: 3933438.